Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...

Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...

Johnson & Johnson said on Thursday it will discontinue a late-stage study of an experimental E.coli vaccine it was developing ...

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) met Wall Street’s revenue expectations in Q4 CY2024, with sales ...

Johnson & Johnson (NYSE: JNJ) is one of the world's largest and most prominent healthcare leaders. Furthermore, revenue ...

Johnson & Johnson — leaders in healthcare innovation, where treatments are smarter and less invasive, and solutions are ...

U.S. President Donald Trump’s threats to slap tariffs on medicines could rattle an industry that has become a cornerstone of ...

A major lawsuit filed on Thursday says pharmaceutical giant Johnson & Johnson has misled customers for decades about the ...

Law firm JGA Saddler is bringing a class action lawsuit against pharmaceutical giant Johnson & Johnson, after starting a ...

A class action has been filed claiming a pharmaceutical giant sold and marketed in New Zealand cold medicines that did not ...

To give some idea of the sheer size of Johnson & Johnson, a glance at its reported sales figure is revealing. In the fourth ...

Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.